Bond Laboratories, Inc. (OTCBB:BNLB) (“Bond Labs”), an international provider of innovative and proprietary nutritional supplements for health conscious consumers marketed primarily through its wholly owned operating division, NDS Nutrition Products (“NDS”), is pleased to announce that the Company is introducing another new, cutting edge product, EvoLean™, to its impressive list of effective diet and weight loss formulations.
“New product innovation is an integral part of our ongoing growth strategy,” stated Bond Laboratories, Inc. CEO, John S. Wilson, “and NDS has a long-standing tradition of developing high-quality dietary and nutritional supplements. EvoLean™, which launches exclusively in GNC franchise locations this week, is yet another example of our commitment to product excellence.” EvoLean’s low-stimulant formula boosts metabolism through a powerful blend of four key ingredients, which have been profiled and highly-touted on television by respected medical professionals. Scott Steil of Nutra Bridge, the exclusive distributor of 7-Keto®, one of EvoLean’s key ingredients added, “We are thrilled to partner with NDS Nutrition to provide a revolutionary and efficacious dietary option to people that demand outstanding results in a low stimulant formula and look forward to working with NDS to deliver additional science-backed solutions in the future that deliver superior results to customers.”
“Our revenue growth is dependent on new product innovation and retail outlet expansion and we believe that EvoLean™ will be a strong enhancement to our already powerful line of sports nutrition and weight loss products, available both domestically and internationally, through the GNC® franchise system. GNC® currently has 1,624 international franchise operations in 56 countries as well as 928 domestic franchise stores. As you can imagine, we are thrilled to introduce another new, quality product into the multi-billion dollar weight loss category,” concluded Mr. Wilson.
About Bond Labs
Bond Laboratories is a manufacturer of innovative nutritional supplements. The Company produces and markets products through its NDS Nutrition division. NDS currently markets 48 products to over 900 GNC franchise locations domestically, and up to 10 products internationally to GNC franchise locations in six countries. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit http://www.bond-labs.com.
Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company’s actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to: the ability to of the Company to continue to grow revenue; the Company’s ability to continue to achieve positive cash flow given the Company's existing and anticipated operating and other costs; and the outcome of the Company’s pending litigation with the U.S. Department of Labor and our former President alleging violations of certain unlawful employment practices in connection with his separation from the Company. Many of these risks and uncertainties are beyond the Company's control. Reference is made to the discussion of risk factors detailed in The Company’s filings with the Securities and Exchange Commission, including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.
Bruce Weinstein, 410-833-0078
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here